Tirzepatide

What Is Tirzepatide?

Tirzepatide is an FDA-approved medication that activates both GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 (glucagon-like peptide-1) receptors. This dual mechanism provides enhanced appetite suppression, improved insulin sensitivity, and more efficient fat metabolism compared to single-pathway medications. Administered as a once-weekly subcutaneous injection, tirzepatide offers a convenient, effective approach to medically supervised weight loss.

Medical Weight Loss — Pre &
Post Care Instructions

Pre-Care:

• Review medical history with provider.
• Eat a small meal before injection.
• Avoid alcohol and fatty foods on injection day.

Post-Care:

• Stay hydrated: 64–80 oz water daily.
• Mild nausea, GI upset, and fatigue are normal initially.
• Avoid greasy meals to reduce nausea.
• Contact provider for severe abdominal pain or vision changes.

When to Contact Us:

Severe vomiting, dizziness, or persistent GI issues.

‍